🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 22 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/02/2005 | 21,63 | 22,45 | 21,63 | 22,35 | +3,62% | 3,82% | 626.600 |
| 22/02/2005 | 22,83 | 23,03 | 21,05 | 21,57 | -3,88% | 8,67% | 1.627.000 |
| 18/02/2005 | 22,33 | 22,49 | 22,24 | 22,44 | +0,72% | 1,12% | 681.400 |
| 17/02/2005 | 22,09 | 22,37 | 21,90 | 22,28 | +0,52% | 2,15% | 503.200 |
| 16/02/2005 | 22,09 | 22,22 | 21,99 | 22,16 | +0,07% | 1,02% | 403.000 |
| 15/02/2005 | 21,97 | 22,30 | 21,93 | 22,15 | +0,68% | 1,66% | 626.600 |
| 14/02/2005 | 21,97 | 22,09 | 21,54 | 22,00 | +0,66% | 2,53% | 627.600 |
| 11/02/2005 | 22,16 | 22,16 | 21,20 | 21,85 | -1,95% | 4,31% | 2.192.000 |
| 10/02/2005 | 22,25 | 22,48 | 22,01 | 22,29 | +0,00% | 2,11% | 668.600 |
| 09/02/2005 | 22,88 | 23,00 | 22,27 | 22,29 | -2,52% | 3,17% | 739.600 |
| 08/02/2005 | 22,63 | 22,98 | 22,39 | 22,86 | +1,67% | 2,59% | 801.000 |
| 07/02/2005 | 22,96 | 22,96 | 22,47 | 22,49 | -1,86% | 2,11% | 745.800 |
| 04/02/2005 | 22,70 | 22,95 | 22,58 | 22,91 | +0,99% | 1,65% | 1.072.600 |
| 03/02/2005 | 22,35 | 22,69 | 22,35 | 22,69 | +1,68% | 1,50% | 1.053.600 |
| 02/02/2005 | 22,06 | 22,47 | 22,05 | 22,31 | +0,61% | 1,90% | 657.200 |
| 01/02/2005 | 21,48 | 22,28 | 21,43 | 22,18 | +3,94% | 3,96% | 1.211.600 |
| 31/01/2005 | 21,39 | 21,58 | 21,27 | 21,34 | +0,40% | 1,45% | 1.261.000 |
| 28/01/2005 | 21,55 | 21,55 | 21,06 | 21,25 | -0,56% | 2,27% | 867.800 |
| 27/01/2005 | 20,95 | 21,52 | 20,95 | 21,37 | +0,73% | 2,75% | 1.006.600 |
| 26/01/2005 | 20,99 | 21,36 | 20,99 | 21,22 | +0,62% | 1,76% | 733.200 |
| 25/01/2005 | 21,23 | 21,50 | 20,96 | 21,09 | -0,92% | 2,54% | 1.505.600 |
| 24/01/2005 | 21,71 | 21,82 | 21,13 | 21,28 | -2,27% | 3,18% | 1.455.600 |
| 21/01/2005 | 21,73 | 22,03 | 21,66 | 21,78 | -0,11% | 1,70% | 711.600 |
| 20/01/2005 | 22,56 | 22,57 | 21,65 | 21,80 | -2,35% | 4,06% | 1.114.400 |
| 19/01/2005 | 22,19 | 22,57 | 22,03 | 22,33 | +1,66% | 2,46% | 1.450.600 |
| 18/01/2005 | 21,37 | 22,05 | 21,21 | 21,96 | +3,27% | 3,91% | 819.000 |
| 14/01/2005 | 20,92 | 21,35 | 20,90 | 21,27 | +1,41% | 2,15% | 654.400 |
| 13/01/2005 | 20,90 | 21,26 | 20,65 | 20,97 | +1,33% | 2,89% | 930.200 |
| 12/01/2005 | 20,55 | 20,75 | 20,38 | 20,70 | +0,05% | 1,80% | 1.656.800 |
| 11/01/2005 | 21,37 | 21,38 | 20,53 | 20,69 | -2,80% | 3,98% | 1.022.200 |